Combined with our previous reported finding that downregulation of LRIG2 inhibits glioblastoma cell growth in vitro[22], our results provided compelling evidences in support of the proposal that full-length LRIG2 served as a tumor promoter in glioblastoma. The gene discussed is LRIG2; the disease is neoplasm.